Real World Effectiveness of Eptinezumab in Participants With Migraine
Clinical trial NCT05284019 · TERMINATED
Trial details
- NCT number
- NCT05284019
- Sponsor
- H. Lundbeck A/S
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2023-02-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.